[HTML][HTML] The Childhood Cancer Survivor Study: a National Cancer Institute–supported resource for outcome and intervention research

…, PC Nathan, JP Neglia, RJ Packer… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Survival for childhood cancer has increased dramatically over the last 40 years with 5-year
survival rates now approaching 80%. For many diagnostic groups, rapid increases in survival …

Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings

…, DA Mulrooney, KC Oeffinger, RJ Packer… - Journal of clinical …, 2009 - ascopubs.org
A primary objective of the Childhood Cancer Survivor Study (CCSS) is to characterize the
major chronic health conditions faced by childhood cancer survivors, and to determine the risk …

Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

C Horbinski, T Berger, RJ Packer, PY Wen - Nature Reviews Neurology, 2022 - nature.com
A new edition of the WHO classification of tumours of the CNS was published in 2021.
Although the previous edition of this classification was published just 5 years earlier, in 2016, …

[PDF][PDF] Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma

RJ Packer, A Gajjar, G Vezina… - Journal of clinical …, 2006 - academia.edu
Packer et al … Packer RJ: Chemotherapy for medulloblastoma/primitive neuroectodermal
tumors of the posterior fossa. Ann Neurol 28:823-828, 1990 5. … Robertson PL, Murasko …

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

LB Rorke, RJ Packer, JA Biegel - Journal of neurosurgery, 1996 - thejns.org
✓ Clinical and pathological features of 52 infants and children with atypical teratoid/rhabdoid
tumor (ATT/RhT) of the central nervous system are defined. This tumor is typically …

[PDF][PDF] Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group …

…, JA Stehbens, SB Shurin, RJ Packer - Journal of Clinical …, 1999 - academia.edu
Purpose: From 1986 to 1992,‘‘eight-drugs-in-oneday’’(8-in-1) chemotherapy both before and
after radiation therapy (XRT)(54 Gy tumor/36 Gy neuraxis) was compared with vincristine, …

[PDF][PDF] Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study

RJ Packer, J Goldwein, HS Nicholson… - Journal of clinical …, 1999 - researchgate.net
PACKER ET AL … PACKER ET AL … Packer RJ: Chemotherapy for medulloblastoma/primitive
neuroectodermal tumors of the posterior fossa. Ann Neurol 28:823-828, 1990 …

Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi‐institutional collaborative project

…, JP Neglia, ME Nesbit, RJ Packer… - … : The Official Journal …, 2002 - Wiley Online Library
Background Increased attention has been directed toward the long‐term health outcomes of
survivors of childhood cancer. To facilitate such research, a multi‐institutional consortium …

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas

RJ Packer, J Ater, J Allen, P Phillips, R Geyer… - Journal of …, 1997 - thejns.org
✓ The optimum treatment of nonresectable low-grade gliomas of childhood remains undecided.
There has been increased interest in the use of chemotherapy for young children, but …

New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study

…, LL Robison, M Stovall, Y Liu, RJ Packer… - Journal of the …, 2006 - academic.oup.com
Background: Subsequent primary neoplasms of the central nervous system (CNS) have
frequently been described as late events following childhood leukemia and brain tumors. …